Institute of Medicine. Hepatitis and liver cancer: A national strategy for prevention and control of hepatitis B and C. Washington: National Academies Press; 2010.
3.
ReinDBWittenbornJSWeinbaumCMSabinMSmithBDLesesneSB. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis2011; 43:66–72.
4.
WeinbaumCMWilliamsIMastEEWangSAFinelliLWasleyA, Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep2008; 57(RR-8):1–20.
5.
ArmstrongGLWasleyASimardEPMcQuillanGMKuhnertWLAlterMJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med2006; 144:705–14.
6.
SmithBDPatelNBeckettGAJewettAWardJW. Hepatitis C virus antibody prevalence, correlates and predictors among persons born from 1945 through 1965, United States, 1999–2008. Paper presented at The Liver Meeting; 2011 Nov 4–8; San Francisco.
7.
ArmstrongGLAlterMJMcQuillanGMMargolisHS. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States. Hepatology2000; 31:777–82.